Graeme Semple
Beacon Clinical Research(US)Eurofins (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Diabetes Treatment and Management, Pharmacological Receptor Mechanisms and Effects, Chemical Synthesis and Analysis
Most-Cited Works
- → A Role for β-Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release(2007)292 cited
- → International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B)(2011)198 cited
- → Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119(2008)142 cited
- → Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists(2005)132 cited
- → Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression(2012)126 cited
- → GnRH Antagonists: A New Generation of Long Acting Analogues Incorporatingp-Ureido-phenylalanines at Positions 5 and 6(2000)